GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Symbol: ELDN on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$2,146,964	1,421,617	+52,677	+3.8%	$1.51	Q4 2025
30 Sep 2025	0%	-0%	$3,546,137	1,368,940	-15,000	-1.1%	$2.59	Q3 2025
30 Jun 2025	0%	+0%	$3,751,041	1,383,940	+717,223	+108%	$2.71	Q2 2025
31 Mar 2025	0%	+0%	$2,261,026	666,717	+3,616		$3.39	Q1 2025
31 Dec 2024	0%	+0%	$2,733,011	663,101	+285,043	+75%	$4.12	Q4 2024
30 Sep 2024	0%	+0%	$941,517	378,058	+33,569	+9.7%	$2.49	Q3 2024
30 Jun 2024	0%	+0%	$909,619	344,489	+163,588	+90%	$2.64	Q2 2024
31 Mar 2024	0%	+0%	$372,783	180,901	+4,862	+2.8%	$2.06	Q1 2024
31 Dec 2023	0%	0%	$316,972	176,039	0		$1.80	Q4 2023
30 Sep 2023	0%	+0%	$241,258	176,039	+6,389	+3.8%	$1.37	Q3 2023
30 Jun 2023	0%	+0%	$232,420	169,650	+40,499	+31%	$1.37	Q2 2023
31 Mar 2023	0%	0%	$304,796	129,151	0		$2.36	Q1 2023
31 Dec 2022	0%	0%	$299,000	129,151	-314	-0.24%	$2.32	Q4 2022
30 Sep 2022	0%	0%	$357,000	129,465	+679	+0.53%	$2.76	Q3 2022
30 Jun 2022	0%	+0%	$314,000	128,786	+2,076	+1.6%	$2.44	Q2 2022
31 Mar 2022	0%	0%	$499,000	126,710	0		$3.94	Q1 2022
31 Dec 2021	0%	0%	$558,000	126,710	-848	-0.66%	$4.40	Q4 2021
30 Sep 2021	0%	+0%	$788,000	127,558	+2,944	+2.4%	$6.18	Q3 2021
30 Jun 2021	0%	+0%	$985,000	124,614	+25,491	+26%	$7.90	Q2 2021
31 Mar 2021	0%	+0%	$1,060,000	99,123	+99,123	NEW	$10.69	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.